We are live on ! Find out more
LCG

Lisanti Capital Growth Portfolio holdings

AUM $455M
1-Year Est. Return 218.66%
This Fund
S&P 500
This Quarter Est. Return
+45.33%
1 Year Est. Return
+218.66%
3 Year Est. Return
+1,489.77%
5 Year Est. Return
+4,348.98%
10 Year Est. Return
+169,910.37%
AUM
$361M
AUM Growth
+$24.6M
Cap. Flow
-$42.3M
Cap. Flow %
-11.73%
Top 10 Hldgs %
20.84%
Holding
153
New
45
Increased
24
Reduced
31
Closed
47

Top Buys

Rank Stock Value
1
CRDO icon
Credo Technology Group
CRDO
+$5.59M
2
TNDM icon
Tandem Diabetes Care
TNDM
+$5.03M
3
MOD icon
Modine Manufacturing
MOD
+$4.87M
4
STRL icon
Sterling Infrastructure
STRL
+$4.85M
5
CELH icon
Celsius Holdings
CELH
+$4.47M

Top Sells

Rank Stock Value
1
PLMR icon
Palomar
PLMR
+$7.93M
2
CWST icon
Casella Waste Systems
CWST
+$6.98M
3
BTSG icon
BrightSpring Health Services
BTSG
+$6.21M
4
KRYS icon
Krystal Biotech
KRYS
+$5.48M
5
MASI
Masimo
MASI
+$5.08M

Sector Composition

Rank Sector Weight
1 Technology 26.37%
2 Industrials 25.9%
3 Healthcare 20.31%
4 Consumer Discretionary 10.72%
5 Consumer Staples 7.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRDO icon
1
Credo Technology Group
CRDO
$43.7B
$9.43M 2.61%
101,855
+95,785
+1,578% +$5.59M
MGNI icon
2
Magnite
MGNI
$3.4B
$8.88M 2.46%
368,015
+224,160
+156% +$3.3M
LITE icon
3
Lumentum
LITE
$80.3B
$8.06M 2.23%
84,765
+40,720
+92% +$2.89M
EYE icon
4
National Vision
EYE
$1.37B
$7.8M 2.16%
338,935
+22,725
+7% +$387K
BOOT icon
5
Boot Barn
BOOT
$4.69B
$7.6M 2.11%
50,030
+11,980
+31% +$1.59M
SPRY icon
6
ARS Pharmaceuticals
SPRY
$586M
$7.33M 2.03%
420,075
+226,245
+117% +$3.26M
AMSC icon
7
American Superconductor
AMSC
$1.38B
$6.63M 1.84%
+180,750
New +$4.44M
ROAD icon
8
Construction Partners
ROAD
$6.25B
$6.62M 1.83%
62,255
-6,705
-10% -$627K
MOD icon
9
Modine Manufacturing
MOD
$9.43B
$6.43M 1.78%
65,270
+54,570
+510% +$4.87M
STRL icon
10
Sterling Infrastructure
STRL
$14.4B
$6.41M 1.78%
+27,780
New +$4.85M
CVLT icon
11
Commault Systems
CVLT
$5.65B
$6.35M 1.76%
36,435
-3,965
-10% -$677K
ANIP icon
12
ANI Pharmaceuticals
ANIP
$1.67B
$6.21M 1.72%
95,165
-10,260
-10% -$668K
OLLI icon
13
Ollie's Bargain Outlet
OLLI
$4.38B
$5.99M 1.66%
45,440
-4,895
-10% -$560K
ULS icon
14
UL Solutions
ULS
$15B
$5.96M 1.65%
81,780
-36,375
-31% -$2.38M
QTWO icon
15
Q2 Holdings
QTWO
$4.06B
$5.66M 1.57%
60,450
-6,215
-9% -$524K
ELF icon
16
e.l.f. Beauty
ELF
$6.14B
$5.6M 1.55%
+45,000
New +$3.84M
BE icon
17
Bloom Energy
BE
$62.1B
$5.5M 1.53%
+230,130
New +$4.46M
RBC icon
18
RBC Bearings
RBC
$15.8B
$5.42M 1.5%
14,095
-1,455
-9% -$514K
CELH icon
19
Celsius Holdings
CELH
$8.35B
$5.39M 1.49%
+116,110
New +$4.47M
CRS icon
20
Carpenter Technology
CRS
$23.6B
$5.31M 1.47%
19,215
-1,880
-9% -$410K
WGS icon
21
GeneDx Holdings
WGS
$2.57B
$5.23M 1.45%
56,615
+27,180
+92% +$2.13M
VSEC icon
22
VSE Corp
VSEC
$6.06B
$5.13M 1.42%
39,150
-4,225
-10% -$526K
KTOS icon
23
Kratos Defense & Security Solutions
KTOS
$9.76B
$5.12M 1.42%
110,135
-107,410
-49% -$3.89M
MRCY icon
24
Mercury Systems
MRCY
$5.32B
$5.07M 1.41%
94,205
+34,750
+58% +$1.69M
GENI icon
25
Genius Sports
GENI
$2.15B
$5.03M 1.39%
483,330
-52,105
-10% -$521K
1
2 3 4 5

Similar funds

HFA
Highland Financial Advisors Wayne, New Jersey $455M AUM 22.51% 1-Year Est. Return
BI
Bulldog Investors Saddle Brook, New Jersey $455M AUM 2.3% 1-Year Est. Return
PIM
Progressive Investment Management Lake Oswego, Oregon $454M AUM 46.56% 1-Year Est. Return
GA
GSG Advisors Mount Laurel, New Jersey $454M AUM 28.38% 1-Year Est. Return
MI
Markowski Investments Tampa, Florida $454M AUM
MC
Miramar Capital Northbrook, Illinois $455M AUM 15.58% 1-Year Est. Return
CFO
Colony Family Offices Charlotte, North Carolina $455M AUM 21.83% 1-Year Est. Return
IIA
Integral Investment Advisors Turlock, California $454M AUM 21.42% 1-Year Est. Return

Lisanti Capital Growth's Q2 2025 Portfolio in Review

As of Q2 2025, Lisanti Capital Growth held 153 positions worth $361M, up 7.3% from $336M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Lisanti Capital Growth withdrew a net $42.3M in Q2 2025, closing 47 positions and reducing 31 holdings. Its most notable exit was Palomar, an estimated $7.93M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 20% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Lisanti Capital Growth opened a new position in Tandem Diabetes Care worth $4.73M.

  • Lisanti Capital Growth's largest Q2 2025 buy was Tandem Diabetes Care: 253,840 shares worth $4.73M.
  • Lisanti Capital Growth added most to Credo Technology Group in Q2 2025, an estimated $5.59M increase.
  • Lisanti Capital Growth's biggest Q2 2025 reduction was Ligand Pharmaceuticals, cutting an estimated $4.48M.
  • Lisanti Capital Growth fully exited Palomar in Q2 2025, selling an estimated $7.93M.
  • Lisanti Capital Growth's ten largest holdings make up 21% of its $361M portfolio in Q2 2025.
  • Lisanti Capital Growth opened 45 new positions and closed 47 in Q2 2025.
  • Lisanti Capital Growth's portfolio value rose 7.3% quarter-over-quarter to $361M.

Based on Lisanti Capital Growth's 13F filing for Q2 2025, filed 7 Aug 2025.